Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek T O'Hagan

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Expert Review of Vaccines|October 13, 2007
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infectionDerek T O'Hagan
AIDS (London, England)|April 18, 2003
Novel adjuvants and delivery systems for HIV vaccinesDerek T O'Hagan, Ed Lavelle
Drug Discovery Today|September 24, 2004
The safety of vaccinesDerek T O'Hagan, Rino Rappuoli
International Journal for Parasitology|June 5, 2003
Recent advances in veterinary vaccine adjuvantsManmohan Singh, Derek T O'Hagan
Expert Review of Vaccines|August 6, 2003
Microparticles as vaccine adjuvants and delivery systemsDerek T O'Hagan, Manmohan Singh
Advanced Drug Delivery Reviews|February 17, 2006
Novel approaches to pediatric vaccine deliveryDerek T O'Hagan, Rino Rappuoli
Pharmaceutical Research|October 23, 2004
Novel approaches to vaccine deliveryDerek T O'Hagan, Rino Rappuoli
NPJ Vaccines|February 8, 2024
The scientific journey of a novel adjuvant (AS37) from bench to bedsideUgo D'Oro, Derek T O'Hagan
Pharmaceutical Research|July 24, 2002
Recent advances in vaccine adjuvantsManmohan Singh, Derek T O'Hagan
Journal of Drug Targeting|November 3, 2010
Bioadhesive delivery systems for mucosal vaccine deliveryBarbara C Baudner, Derek T O'Hagan
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Expert Review of Vaccines|October 13, 2007
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infectionDerek T O'Hagan
AIDS (London, England)|April 18, 2003
Novel adjuvants and delivery systems for HIV vaccinesDerek T O'Hagan, Ed Lavelle
Drug Discovery Today|September 24, 2004
The safety of vaccinesDerek T O'Hagan, Rino Rappuoli
International Journal for Parasitology|June 5, 2003
Recent advances in veterinary vaccine adjuvantsManmohan Singh, Derek T O'Hagan
Expert Review of Vaccines|August 6, 2003
Microparticles as vaccine adjuvants and delivery systemsDerek T O'Hagan, Manmohan Singh
Advanced Drug Delivery Reviews|February 17, 2006
Novel approaches to pediatric vaccine deliveryDerek T O'Hagan, Rino Rappuoli
Pharmaceutical Research|October 23, 2004
Novel approaches to vaccine deliveryDerek T O'Hagan, Rino Rappuoli
NPJ Vaccines|February 8, 2024
The scientific journey of a novel adjuvant (AS37) from bench to bedsideUgo D'Oro, Derek T O'Hagan
Pharmaceutical Research|July 24, 2002
Recent advances in vaccine adjuvantsManmohan Singh, Derek T O'Hagan
Journal of Drug Targeting|November 3, 2010
Bioadhesive delivery systems for mucosal vaccine deliveryBarbara C Baudner, Derek T O'Hagan
Pageof 12